P37.3
Congenital falciparum malaria
Clinical Classification Guidelines
Medical Intelligence & Overview
Congenital falciparum malaria is a rare but serious condition where a newborn is infected with the malaria parasite, Plasmodium falciparum, from their mother during pregnancy. This form of malaria can pose significant health risks to the infant, requiring prompt diagnosis and management. It occurs when malaria-infected blood crosses the placenta or during childbirth, leading to infection in the baby. Recognizing this condition is crucial because early treatment can significantly improve outcomes for affected infants.
Causes & Symptoms
Clinical Causes: Maternal malaria infection during pregnancy, especially with Plasmodium falciparum Transmission of the malaria parasite across the placenta (congenital transmission) Infection acquired during childbirth from an infected mother Inadequate treatment or control of malaria in pregnant women
Key Symptoms: Fever, often recurring or irregular Poor feeding and irritability Pale skin and mucous membranes Sweating and chills Anemia, resulting in fatigue and weakness Enlarged liver and spleen Jaundice, indicated by yellowing of the skin and eyes Respiratory distress in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Healthcare providers typically perform blood tests, such as microscopy to identify the parasite or rapid diagnostic tests (RDTs). In some cases, additional blood work may be necessary to assess anemia severity and organ function. Prenatal history and maternal health records can also provide important clues for early diagnosis. Confirming the presence of Plasmodium falciparum in the infant's blood is essential for diagnosis.
Treatment Protocols: Treating congenital falciparum malaria usually involves antimalarial medications specifically effective against Plasmodium falciparum. The choice of medication depends on the severity of infection, the infant’s age, weight, and local drug resistance patterns. Supportive care such as blood transfusions for anemia, hydration, and symptomatic management may also be necessary. Early intervention is vital to prevent complications and improve recovery prospects. Close monitoring during and after treatment is essential to ensure the infection is fully cleared.
Clinical Advice & FAQs
Billing Guidance
Is P37.3 a billable ICD-10 code?
Yes, P37.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P37.3?
Clinical documentation must specify the nature of Congenital falciparum malaria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference